RESUMO
Native and exotic Brazilian plants collected in the State of Minas Gerais were evaluated for their anticancer potential. Methanol extracts from leaves of 51 plant species were tested for cytotoxicity against four tumor cell lines: B16 (murine skin), HL-60 (human leukemia), MCF-7 (human breast), and HCT-8 (human colon). Plant extracts that exhibited IC(50) values less than 30 microg/ml against any tumor cell line were tested on sea urchin egg development and mouse erythrocytes. In addition, all extracts were evaluated for their general toxicity using the brine shrimp lethality assay. The most active extracts against the tumor cells were those obtained from Lantana fucata, Copaifera langsdorffii, and Momordica charantia. These three extracts inhibited sea urchin development from the first cleavage, but those from C. langsdorffii and M. charantia were very active against mouse erythrocytes. Only the L. fucata extract presented no hemolytic activity. Consequently, although the extracts of L. fucata, M. charantia, and C. langsdorffii could be useful in the development of new anticancer products, the first of these extracts is the most promising since it did not present unspecific toxicity, as suggested by negative results obtained with brine shrimp lethality and mouse erythrocytes assays.
Assuntos
Antineoplásicos Fitogênicos/isolamento & purificação , Extratos Vegetais/isolamento & purificação , Plantas Medicinais , Animais , Antineoplásicos Fitogênicos/uso terapêutico , Artemia , Brasil , Linhagem Celular Tumoral , Avaliação Pré-Clínica de Medicamentos/métodos , Células HL-60 , Humanos , Melanoma Experimental/tratamento farmacológico , Camundongos , Extratos Vegetais/uso terapêuticoRESUMO
To contribute to the development of antibacterial products from propolis produced by native Brazilian bees, twenty-nine samples of propolis collected from hives in the state of Minas Gerais, Brazil, were screened for in vitro activity against Aeromonas hydrophila, Bacillus subtilis, Pseudomonas aeruginosa, and Staphylococcus aureus. Among the samples from native Brazilian bees, only that from Frieseomelitta varia (Lepeletier, 1836) inhibited in vitro bacterial growth. Consequently, this propolis underwent fractionation by chromatographic methods monitored through Agar-diffusion assays with these bacteria, which resulted in the isolation and identification of 3,5-diprenyl-4-hydroxycinnamic acid (artepillin C), which showed MIC of 62.5 and 250 µg/mL against B. subtilis and S. aureus, respectively. This result indicates the potential of F. varia to produce therapeutic propolis.
Para contribuir para o desenvolvimento de produtos antibacterianos obtidos de própolis produzidos por abelhas nativas do Brasil, 29 tipos de própolis coletados de diferentes colméias no Estado de Minas Gerais, Brasil, foram avaliados quanto à atividade in vitro contra Aeromonas hydrophila, Bacillus subtilis, Pseudomonas aeruginosa, e Staphylococcus aureus. Dentre as amostras de abelhas nativas, somente a de Frieseomelitta varia (Lepeletier, 1836) inibiu, em teste in vitro, o crescimento bacteriano. Consequentemente, essa própolis foi submetida a métodos cromatográficos para o fracionamento biomonitorado por teste de difusão em Agar com as referidas bactérias, o que resultou no isolamento e identificação do ácido 3,5-diprenil-4-hidroxicinâmico (artepelin C), que apresentou CIM de 62,5 e 250 µg/mL frente a B. subtilis e S. aureus, respectivamente. Esses resultados indicam o potencial de F. varia para a produção de própolis terapêutica.